Advertisement

Federal Judge Revives Legal Effort To Limit Access to Abortion Pill

0
By Carole Tanzer Miller HealthDay Reporter WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- Efforts to limit access to the abortion drug mifepristone have received a...

GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss

0

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders

Drop in Episiotomy Not Tied to Increase in Obstetric Anal Sphincter Injury for Most...

0

Study from France shows difference in overall prevalence of OASI was not statistically significant

Director of the National Institutes of Health Steps Down

0

Monica M. Bertagnolli has served in the role for just over a year

Zoledronate Prevents Morphometric Vertebral Fractures Over 10 Years

0

Zoledronate administered at baseline and five years effective for preventing fragility fracture, any fracture, major osteoporotic fracture

Cancer Mortality Continued to Decline Through 2022

0

However, increase seen in incidence in women, especially for middle-aged and younger women

Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer

0

T-DM1 sustained the improvement in invasive disease-free survival over trastuzumab in HER2-positive early breast cancer

ACIP Immunization Schedules Issued for Children, Adults

0

Changes to both schedules include new and updated recommendations for COVID-19 vaccine, change to trivalent influenza vaccines

Hormone Therapy Not Associated With Glioma Risk in Women

0

Similar findings with no significant association seen when accounting for hormone therapy status and duration of use

AI-Supported Double Mammogram Reading Improves Detection Rate

0

Superior breast cancer detection rate seen compared with standard double-reading, without negatively affecting recall rate